Cencora Inc (NYSE:COR)
$ 324.69 -6.26 (-1.89%) Market Cap: 61.96 Bil Enterprise Value: 71.06 Bil PE Ratio: 24.12 PB Ratio: 20.31 GF Score: 72/100

Cencora, Inc. at Wells Fargo Healthcare Conference Transcript

Sep 08, 2026 / 01:30PM GMT
Stephen Baxter
Wells Fargo Securities LLC - Analyst

Hi, everyone. Thanks again for joining us. So we're really pleased to have Cencora for our next fireside chat. So Cencora is a drug distributor and provider of pharma-focused services. With us from the company are Bob Mauch, the CEO -- President and CEO; and Eva Boratto, EVP and CFO.

So I've been with us in the audience.

So first, I wanted to see if you wanted to make any kind of introductory comments or whether we should just really hop right into Q&A.

Questions & Answers

Robert Mauch
Cencora, Inc. - President, Chief Executive Officer, Director

Yes. Maybe just a quick word. Hi everyone, thank you very much for being here. We're in the midst of an excellent fiscal 2026. We reported last month, our third quarter earnings, which demonstrated continued growth in our areas of focus, which really are the specialty pharmaceutical areas, both in the physician part of our business as well.

As in health systems, we also had the opportunity to opportunistically repurchase $1

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot